A strategic imperative for risk mitigation, compliance, and client success
Oversight monitoring has emerged as a critical function in clinical trial management, driven by increasing regulatory scrutiny, operational complexity, and the need for proactive risk mitigation. Karis Sadie shares insights into the evolving role of oversight monitoring, its strategic value, and the challenges clients face in adopting it.
Through real-world examples—including Catalyst Flex’s pivotal role in a client’s US Food and Drug Administration (FDA) audit—it becomes clear that oversight monitoring is not just a regulatory checkbox but a strategic advantage.
Download this position paper and learn why oversight monitoring is so essential and how to incorporate it in your trial.
